Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$204.13 - $302.4 $2.33 Million - $3.45 Million
-11,400 Closed
0 $0
Q1 2022

Apr 14, 2022

BUY
$255.51 - $362.11 $2.91 Million - $4.13 Million
11,400 New
11,400 $5,000
Q3 2020

Oct 27, 2020

SELL
$175.56 - $226.45 $702,240 - $905,800
-4,000 Closed
0 $0
Q2 2020

Jul 22, 2020

BUY
$118.84 - $189.72 $475,360 - $758,880
4,000 New
4,000 $11,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.49B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.